Home › NDC Lookup › RxCUI directory › RxCUI 2602839

Magnesium hydroxide 600 MG Chewable Tablet — RxCUI 2602839

RxNorm drug concept · Semantic clinical drug
RxCUI 2602839 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2602839
Official nameMagnesium hydroxide 600 MG Chewable Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Magnesium Hydroxide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product you pick up. Most magnesium hydroxide products — like Dulcolax liquid, Colace Fast-Acting Saline Laxative, MiraFAST soft chews, and many Milk of Magnesia...
  • What is magnesium hydroxide actually used for?
  • Yes, a few things matter here. If you're taking a liquid or suspension, shake it well before every use. Whatever form you take, follow it with a full 8-ounce glass of water or anot...
  • How should I take it — does it matter when or how I drink it?
📖 Read our full Magnesium Hydroxide guide →

🕸️ Concept Web — How Magnesium hydroxide 600 MG Chewable Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Magnesium hydroxide 600 MG Chewable Tablet RxCUI 2602839

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Magnesium hydroxide 6581
  2. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Magnesium hydroxide Chewable Tablet 372685
    • Magnesium hydroxide Chewable Product 1295473
    • Magnesium hydroxide Oral Product 1157489
    • Magnesium hydroxide Pill 1157490
    • Chewable Tablet 91058
    • Chewable Product 1294716
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Magnesium hydroxide 600 MG 438213

Showing up to 8 concepts per family — 10 of 10 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Magnesium hydroxide 600 MG SCDC · 438213
  • Magnesium hydroxide Chewable Tablet SCDF · 372685
  • Magnesium hydroxide Chewable Product SCDG · 1295473
  • Magnesium hydroxide Oral Product SCDG · 1157489
  • Magnesium hydroxide Pill SCDG · 1157490

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2602839 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
41167-0256-00 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (41167-0256-0) Dulcolax Chewy Bites Assorted Fruits Chattem, Inc. 2022-06-06
41167-0257-00 30 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC (41167-0257-0) Dulcolax Chewy Fruit Bites Cherry Berry Chattem, Inc. 2022-06-06
Observed labelers: Chattem, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.